News
AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 billion in manufacturing.
Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...
With its latest $50 billion U.S. manufacturing investment and record U.S. growth, is British AstraZeneca looking at itself as ...
The Anglo-Swedish pharmaceutical giant said Tuesday that for the second quarter, core earnings per share rose to $2.17 from $1.98 in the same period a year prior. Revenue increased to $14.46 billion ...
(Alliance News) - AstraZeneca PLC on Tuesday reported better-than-expected second quarter revenue, and raised its dividend, boosted by strong sales from its cancer portfolio.
(Alliance News) - AstraZeneca raised its dividend as drug growth pushed earnings higher, Barclays launched a new buyback programme after profit jumped while Greggs saw profit fall despite higher sales ...
AstraZeneca PLC (NASDAQ: AZN) ranks among the stocks to benefit from an onshoring boom. AstraZeneca PLC (NASDAQ:AZN) ...
Democrats assert in the court case that the vote of a Senate committee rejecting the appointees means they cannot serve. A ...
The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...
FOX 5 Washington DC on MSN2d
AstraZeneca to build drug manufacturing plant in VirginiaPrincess Charlotte, 10, Makes Surprise Appearance with Prince William at Her First Overseas Soccer Game 'Married... With Children' stars expose behind-the-scenes drama of beloved sitcom The 2028 ...
AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.
In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results